Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil versus donepezil + betahistine for autism spectrum disorder symptoms
IRCT20160905029714N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Autism Spectrum Disorder (ASD) comparing Donepezil with Donepezil + betahistine (2 arms). Primary endpoints: Social Responsiveness Scale total score, Autism Behavior Checklist-2 total score and 1 more. Started Feb 2022; status: completed.
02
Drugs
donepezilbetahistine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT20160905029714N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160905029714N2.